This Is MS - Clinical Trial for Low Dose Naltrexone & Crohn's Disease

Crohn's is another autoimmune disease and treatments can be applicable to multiple sclerosis (e.g., Antegren). "Dr. Jill Smith is currently enrolling patients in a 4 month study to test the effectiveness of a low dose of naltrexone in offering relief to patients suffering from symptoms of Crohn's Disease." Please see the following link for more info: http://www.hmc.psu.edu/colorectal/research/naltrexone.htm